Lovastatin, mevastatin, pravastatin and monacolin J were produced using Aspergillus terreus strains. Mevastatin (170 mg/l) was obtained at 14 days from the A1 strain, lovastatin (256 mg/l) at 21 days from the A2 strain and pravastatin (270-300 mg/l) at 14 days from both the A1 and A2 strains grown on defatted soybean flour. Similar yields of monacolin J (5-10 mg/l) were detected for both strains. Fermentation carried out by adding glycerol to A1 7-d old cultures gave 244 mg lovastatin/l at 14 days employing whole soybean flour. A new extraction procedure was applied to an A2 19-d old culture on the mycelium and the culture filtrate separately. Recovery yield showed that 83% lovastatin was associated with the mycelium and 17% was free in the culture filtrate.
Introduction
Statins are fungal secondary metabolites which inhibit hydroxy-methylglutaryl coenzyme A (HMG-CoA) reductase (EC 1.1.1.34) as the first committed enzyme of cholesterol biosynthesis (Alberts, 1988) . Statins are therefore used as cholesterol-lowering drugs. All statins possess a common structure, a hexahydro-naphthalene system and a ␤-hydroxylactone; their differences are due to side chains and methyl groups around the ring (Fig. 1 ). Lovastatin has a methylbutyryl side-chain at 8-␣ and a methyl group in 6-␣ of the naphthalene ring; mevastatin lacks the methyl group; pravastatin is the 6-hydroxy sodium salt analogue of mevastatin; monacolin J lacks the lovastatin methylbutyryl side-chain.
The reversible inhibitory activity of statins on HMG-CoA reductase is due to the close structural analogy of their acid form with HMG-CoA, the natural substrate for the enzyme (Alberts et al., 1980) . Endo et al. (1976) described a process for the production and purification of mevastatin from Penicillium citrinum. After this, lovastatin was obtained from cultures of Monascus ruber (Negishi et al., 1986) and in 1980 an industrial process for its production was set-up using Aspergillus terreus which yielded nearly 180 mg lovastatin/l, glycerol being the carbon source in a fed-batch culture (Buckland et al., 1989) .
The present paper describes a process for statins production from cultures of Aspergillus terreus, and a new extraction procedure that was used to isolate lovastatin in the pure form.
Materials and methods

Microbial strains and culture conditions
Aspergillus terreus MIM A1 and A2 strains (Industrial Microbiology Collection of the University of Milan) were grown in 750 ml Erlenmeyer flasks, containing 100 ml medium of the following composition (g/l): glycerol 70, peptone 8, MgSO 4 7H 2 O 1, glucose 30, pH 6.4, sterilized at 118°C for 20 min. The medium was supplemented with 30 g whole or defatted soybean flour/l. Each flask was Biotechnology Techniques, Vol 12, No 7, July 1998 , pp. 529-532 © 1998 Chapman & Hall Biotechnology Techniques ⋅ Vol 12 ⋅ No 7 ⋅ 1998 inoculated with a standard spore suspension, prepared using 5 g Tween 80/l in distilled H 2 O, from a PDA (Potato Dextrose Agar) culture, incubated at 25°C for 10-15 days on a reciprocal shaker at 60 strokes/min.
Synthesis of monacolin J Monacolin J was experimentally obtained as follows: 100 mg of lovastatin were dissolved in 1 M methanolic KOH (20 ml). The solution was maintained at 65°C and the reaction monitored by HPLC. After 4 hours the solution was diluted with acidified H 2 O (pH 3 with 1 M HCl, 100 ml) and then extracted with ethyl acetate (2 ϫ 40 ml). The combined extracts were dried (Na 2 SO 4 ) and evaporated. The crude product was flash chromatographed (Clark Still et al., 1978) to give the desired product. Monacolin J was then crystallized with benzene (5 ml), characterized by 13 C NMR and employed as standard in subsequent experiments.
Isolation of statins from the culture filtrate Culture filtrate (2 l) obtained by filtration was acidified to pH 3 with trifluoroacetic acid and extracted with ethyl acetate (3 ϫ 600 ml). The combined extracts were dried (Na 2 SO 4 ) and concentrated to a final volume of 4 ml. The complete lactonization of statins was achieved by adding benzene (5 ml) and TFA (100 l), drying and concentrating the batch as above.
Isolation of statins from the mycelium
The mycelial mass obtained by filtration from a 2 l culture was washed with 0.02 M HCl (300 ml), stirring at room temperature for 1 h. The mycelium was then filtered and extracted with dichloromethane (2 ϫ 500 ml) and with ethyl acetate (500 ml), stirring at 40°C for 2 h. Both extracts were dried (Na 2 SO 4 ) and concentrated to a final volume of 4 ml. Statins lactonization was carried out as reported for the culture filtrate extracts.
Analysis
Identification and quantification of statins were carried out on the culture filtrates and extracts by HPLC, using a Merck-LiChrospher 60 RP-Select B reverse phase column with a UV detector (238 nm). A mobile phase mixture of trifluoroacetic acid (0.05%) and acetonitrile (55:45 and 67:33 v/v) at a flow rate of 1 ml/min was used.
13
C NMR spectra were recorded at 22°C using a Bruker AC-200 spectrometer at 50 Mhz.
Chemicals and reagents
HPLC-grade acetonitrile was supplied from Merck. Lovastatin, mevastatin and pravastatin were obtained from Sigma.
Results and discussion
Production of statins
In preliminary experiments the production of statins by Aspergillus terreus strains MIM A1 and A2, grown in submerged culture in a medium supplemented with whole or defatted soybean flour, was examined.
As lovastatin is produced as a mixture of lactone and free hydroxyacid form, a determination procedure was set-up to ensure a correct quantification. Statins quantification has always been carried out on extracts from in toto culture, by the literature extraction procedure (Negishi et al., 1986) . Investigations on lovastatin standard solution have indicated that sample pH is important for lovastatin detection and quantification. In fact, in acid conditions HPLC chromatograms reveal a balance between the lactone and the hydroxyacid form, there being two peaks with different retention times. On the contrary under alkaline conditions the detection of lovastatin was easier: lovastatin is found only in the free hydroxyacid salt form, as is mevastatin. Instead, for pravastatin, which is produced as a ␤-hydroxyacid, there was no change in the retention time within the HPLC column when the pH was varied.
Thus in this first part of the research, statins production was determined not on acidified samples, as reported in the literature, but on the fully alkalized culture. Under these conditions any statins present in the lactone form are transformed into the corresponding hydroxyacid. This method has not, till now, been reported in the literature.
Using alkaline conditions and a medium containing defatted soybean flour, the A1 strain produced mainly mevastatin (170 mg/l after 14 days) and the A2, lovastatin (256 mg/l after 21 days).
Pravastatin standard showed, in the employed HPLC column elution conditions, trifluoroacetic acid (0.05%) and acetonitrile 55:45, a retention time of 3.19 min, too short to be unequivocally identified, especially in samples with marked amounts of metabolites having similar low retention times. However, changing the mobile phase by increasing the trifluoroacetic acid to acetonitrile proportions (67:33 v/v), led to a retention time delay (7.4 min). This allowed pravastatin determination and, in fact, both strains showed very good production (270-300 mg/l) in the medium containing defatted soybean flour at 14 days.
Also monacolin J was detected. This molecule is the precursor of lovastatin, the difference being the absence of the methylbutyryl side-chain, which is incorporated only in the last step of the biosynthetic pathway (Juzlová et al., M. Manzoni et al. 
